ReviewMolecular biology reports2025

Anti-atherogenic immune checkpoint TIM-3 as a promising pharmacologic target toward ischemic heart diseases: a prospective review.

Aysa Rezabakhsh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.